Please login to the form below

Not currently logged in

Edelman extends PR contract with Leo Pharma

Will continue to work together in Germany

Edelman's Frankfurt office sees its contract with LEO Pharma renewed following a successful year.

The renewed contract will involve Edelman having responsibility for the strategic planning and implementation of trade activities in the field of blood coagulation disorders in Germany, said LEO Pharma.

“Last year Edelman successfully supported us with their health industry expertise, which was essential in the communications process during our first benefit assessment in the area of dermatology,” said LEO Pharma spokesman Thomas Schick.

“We are happy to work with them now in the thrombosis business division”.

With this renewed contract, Edelman is continuing to expand its portfolio of clients in the field of classical technical communication, the agency said.

“With LEO, we're now working on a couple of topics – not campaigns,” Martin Flörkemeier, managing director of Edelman in Germany, told PMLiVE.

“Knowing that they've just awarded us this new piece of work because of their high satisfaction with our strategic competence, service quality and exactly the right team match, we would hope that this partnership will remain healthy and potentially grow further in the future.”

Founded in 1908, LEO Pharma provides medical solutions in more than 100 countries. It is headquartered in Denmark, owned by the LEO Foundation and employs 4,800 staff worldwide.

6th March 2014

From: Marketing



Featured jobs

Subscribe to our email news alerts


Add my company
infill healthcare communication

infill is a dynamic and innovative, international healthcare agency with >25 years' experience in delivering healthcare communication, medical education and...

Latest intelligence

Waking the sleeping giant
The lights are coming on for healthcare delivery in Africa...
How to get rep buy-in for multi-channel
How do you manage a team who may be resistant to change?...
Blog: Digital therapeutics: within our reach?
Digital therapeutics is a hot topic right now. By using digital technology to manage, treat or even prevent chronic conditions, digital therapeutics is promising to revolutionise healthcare. But is this...